JB Jones, PhD, MBA
Articles
November 1st 2023
Characterizing Obesity in a Large Health Care Delivery System.
Alice Pressman, PhD, MS JB Jones, PhD, MBA Xiangyi Xu, MS Alexandra Scott, MA Sara Alvarez, PharmD Stephanie Watkins, PhD Emily Durden, PhD
The prevalence of obesity in the Sutter Health system between 2015 and 2020 was 35%. Differences by race/ethnicity, health insurance, smoking status, and comorbidities were examined.
November 1st 2023
Characterizing Obesity in a Large Health Care Delivery System
Alice Pressman, PhD, MS JB Jones, PhD, MBA Xiangyi Xu, MS Alexandra Scott, MA Sara Alvarez, PharmD Stephanie Watkins, PhD Emily Durden, PhD
The prevalence of obesity in the Sutter Health system between 2015 and 2020 was 35%. Differences by race/ethnicity, health insurance, smoking status, and comorbidities were examined.
April 20th 2017
Medication Burden in Patients With Acute Coronary Syndromes
Eric A. Wright, PharmD, MPH Steven R. Steinhubl, MD JB Jones, PhD, MBA Pinky Barua, MSc, MBA Xiaowei Yan, PhD Ryan Van Loan, BA Glenda Frederick, BA Durgesh Bhandary, MS David Cobden, Ph
Patients endure heavy medication complexity following hospital discharge for acute coronary syndrome.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: November 1st 2024 | Updated: November 21st 2024
Table Multiple Myeloma Trials November 2024
